Thus, DLBCL cells with HAT gene mutations have higher levels of active BCL6 and lower levels of active p53 [88], consistent with decreased acetylation being associated with increased tumor cell growth. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.